| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | BIENAIME JEAN JACQUES Director | Mixed | 0 | +0.00%43,415 | $19.43 | $408,080 | View SEC filing | |
| 2026-05-19 | BIENAIME JEAN JACQUES Director | Purchase | +5,000 | +13.02%43,415 | $20.70 | $103,500 | View SEC filing | |
| 2026-04-03 | Rosett Max Chief Financial Officer | Sale | -65,000 | -54.60%54,037 | $21.92 | $1,424,916 | View SEC filing | |
| 2026-04-03 | Higgins Jack Chief Scientific Officer | Sale | -9,438 | -30.02%22,000 | $21.64 | $204,238 | View SEC filing | |
| 2026-03-31 | SIEGALL CLAY B President and CEO | Purchase | +25,450 | +3.83%690,704 | $19.67 | $500,602 | View SEC filing | |
| 2026-03-23 | WAGENHEIM PHILIP Director | Sale | -65,000 | -16.00%341,147 | $20.55 | $1,335,626 | View SEC filing | |
| 2026-03-12 | BIENAIME JEAN JACQUES Director | Purchase | +2,000 | +5.49%38,415 | $21.84 | $43,670 | View SEC filing | |
| 2025-12-30 | SIEGALL CLAY B President and CEO | Purchase | +4,729 | +0.72%665,254 | $21.15 | $100,018 | View SEC filing | |
| 2025-12-23 | Barchas Isaac Director | Sale | -383,200 | -8.60%4,073,613 | $21.74 | $8,330,080 | View SEC filing | |
| 2025-12-22 | Tsai Philip Chief Technical Officer | Purchase | +10,000 | +30.03%43,300 | $20.49 | $204,900 | View SEC filing | |
| 2025-12-22 | SIEGALL CLAY B President and CEO | Purchase | +7,278 | +0.85%860,525 | $20.48 | $149,053 | View SEC filing | |
| 2025-12-18 | SIEGALL CLAY B President and CEO | Purchase | +46,511 | +5.77%853,247 | $21.50 | $999,987 | View SEC filing | |
| 2025-06-03 | BIENAIME JEAN JACQUES Director | Purchase | +5,000 | +15.92%36,415 | $9.38 | $46,900 | View SEC filing | |
| 2025-03-26 | BIENAIME JEAN JACQUES Director | Purchase | +7,800 | +33.03%31,415 | $7.78 | $60,684 | View SEC filing | |
| 2025-03-26 | SIEGALL CLAY B President and CEO | Purchase | +137,100 | +20.47%806,736 | $7.29 | $999,459 | View SEC filing | |
| 2025-03-25 | BIENAIME JEAN JACQUES Director | Purchase | +7,000 | +42.13%23,615 | $8.21 | $57,470 | View SEC filing | |
| 2025-03-25 | Tsai Philip Chief Technology Officer | Purchase | +12,300 | +58.57%33,300 | $8.42 | $103,566 | View SEC filing | |
| 2025-02-03 | SIEGALL CLAY B President and CEO | Purchase | +150,000 | +28.87%669,636 | $7.75 | $1,162,500 | View SEC filing | |
| 2024-11-25 | SIEGALL CLAY B President and CEO | Purchase | +100,000 | +23.83%519,636 | $9.62 | $962,181 | View SEC filing | |
| 2024-11-25 | Lechleider Robert Chief Medical Officer | Purchase | +15,805 | +100.00%15,805 | $9.48 | $149,800 | View SEC filing | |
| 2024-11-25 | Tsai Philip Chief Technology Officer | Purchase | +21,000 | +100.00%21,000 | $9.43 | $198,030 | View SEC filing | |
| 2024-09-20 | Rosett Max Chief Financial Officer | Sale | -14,380 | -23.25%47,476 | $16.01 | $230,224 | View SEC filing | |
| 2024-08-19 | BIENAIME JEAN JACQUES Director | Purchase | +7,000 | +72.80%16,615 | $13.94 | $97,608 | View SEC filing | |
| 2024-08-19 | Higgins Jack Chief Scientific Officer | Sale | -3,524 | -18.05%16,000 | $13.92 | $49,072 | View SEC filing | |
| 2024-05-22 | BIENAIME JEAN JACQUES Director | Purchase | +2,000 | +26.26%9,615 | $13.57 | $27,140 | View SEC filing |
1-25 of 36
